메뉴 건너뛰기




Volumn 33, Issue 1, 2011, Pages 99-105

The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man

Author keywords

[No Author keywords available]

Indexed keywords

ITOPRIDE; PLACEBO; PROKINETIC AGENT;

EID: 78650025715     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04487.x     Document Type: Article
Times cited : (27)

References (23)
  • 1
    • 0028555362 scopus 로고
    • Characterization of acetylcholinesterase-inhibition by itopride
    • Iwanaga Y, Kimura T, Miyashita N, et al. Characterization of acetylcholinesterase-inhibition by itopride. J J Pharmacol 1994; 66: 317-22.
    • (1994) J J Pharmacol , vol.66 , pp. 317-322
    • Iwanaga, Y.1    Kimura, T.2    Miyashita, N.3
  • 2
    • 0030018836 scopus 로고    scopus 로고
    • Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs
    • Iwanaga Y, Miyashita N, Saito T, Morikawa K, Itoh Z,. Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs. J J Pharmacol 1996; 71: 129-37.
    • (1996) J J Pharmacol , vol.71 , pp. 129-137
    • Iwanaga, Y.1    Miyashita, N.2    Saito, T.3    Morikawa, K.4    Itoh, Z.5
  • 3
    • 56649109718 scopus 로고    scopus 로고
    • Potentiation by cholinesterase inhibitors of cholinergic activity in rat isolated stomach and colon
    • Cellek S, Sanger G,. potentiation by cholinesterase inhibitors of cholinergic activity in rat isolated stomach and colon. Pharm Res 2008; 58: 297-301.
    • (2008) Pharm Res , vol.58 , pp. 297-301
    • Cellek, S.1    Sanger, G.2
  • 4
    • 42249093021 scopus 로고    scopus 로고
    • Effect of itopride on gastric emptying in longstanding diabetes mellitus
    • Stevens J, Russo A, Maddox A, et al. Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastro Motil 2008; 20: 456-63.
    • (2008) Neurogastro Motil , vol.20 , pp. 456-463
    • Stevens, J.1    Russo, A.2    Maddox, A.3
  • 5
    • 33846916642 scopus 로고    scopus 로고
    • Trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers
    • Choung R, Talley N, Peterson J, et al. Trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil 2007; 19: 180-7.
    • (2007) Neurogastroenterol Motil , vol.19 , pp. 180-187
    • Choung, R.1    Talley, N.2    Peterson, J.3
  • 6
    • 33344478892 scopus 로고    scopus 로고
    • A placebo-controlled trial of itopride in functional dyspepsia
    • Holtmann G, Talley N, Liebregts T, Adam B, Parow C,. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006; 354: 832-40.
    • (2006) N Engl J Med , vol.354 , pp. 832-840
    • Holtmann, G.1    Talley, N.2    Liebregts, T.3    Adam, B.4    Parow, C.5
  • 7
    • 44149124107 scopus 로고    scopus 로고
    • Itopride in functional dyspepsia: Results of two phase III multicentre, randomised, double-blind, placebo-controlled trials
    • Talley NJ, Tack J, Ptak T, Gupta R, Giguère M,. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 2008; 57: 740-6.
    • (2008) Gut , vol.57 , pp. 740-746
    • Talley, N.J.1    Tack, J.2    Ptak, T.3    Gupta, R.4    Giguère, M.5
  • 8
    • 33746709974 scopus 로고    scopus 로고
    • The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus
    • Global Consensus Group.
    • Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1900-1920
    • Vakil, N.1    Van Zanten, S.V.2    Kahrilas, P.3    Dent, J.4    Jones, R.5
  • 9
    • 23144456466 scopus 로고    scopus 로고
    • Effect of itopride, a new prokinetic, in patients with mild GERD: A pilot study
    • Kim YS, Kim TH, Choi CS, et al. Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study. World J Gastroenterol 2005; 11: 4210-4.
    • (2005) World J Gastroenterol , vol.11 , pp. 4210-4214
    • Kim, Y.S.1    Kim, T.H.2    Choi, C.S.3
  • 11
    • 0036135330 scopus 로고    scopus 로고
    • Anti-relaxation therapy in GORD
    • Tack J, Sifrim D,. Anti-relaxation therapy in GORD. Gut 2002; 50: 6-7.
    • (2002) Gut , vol.50 , pp. 6-7
    • Tack, J.1    Sifrim, D.2
  • 12
    • 21844442160 scopus 로고    scopus 로고
    • Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease
    • Tack J,. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease. Curr Opin Gastroenterol 2005; 21: 454-60.
    • (2005) Curr Opin Gastroenterol , vol.21 , pp. 454-460
    • Tack, J.1
  • 13
    • 55649117966 scopus 로고    scopus 로고
    • Reflux inhibitors: A new approach for GERD?
    • Boeckxstaens GE,. Reflux inhibitors: a new approach for GERD? Curr Opin Pharmacol 2008; 8: 685-9.
    • (2008) Curr Opin Pharmacol , vol.8 , pp. 685-689
    • Boeckxstaens, G.E.1
  • 14
    • 0028891589 scopus 로고
    • Criteria for objective definition of transient lower esophageal sphincter relaxation
    • Holloway RH, Penagini R, Ireland AC,. Criteria for objective definition of transient lower esophageal sphincter relaxation. Am J Physiol 1995; 268: G128-33.
    • (1995) Am J Physiol , vol.268
    • Holloway, R.H.1    Penagini, R.2    Ireland, A.C.3
  • 15
    • 33846916642 scopus 로고    scopus 로고
    • A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers
    • Choung RS, Talley NJ, Peterson J, et al. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil 2007; 19: 180-7.
    • (2007) Neurogastroenterol Motil , vol.19 , pp. 180-187
    • Choung, R.S.1    Talley, N.J.2    Peterson, J.3
  • 16
    • 49349099524 scopus 로고    scopus 로고
    • Influence of itopride and domperidone on gastric tone and on the perception of gastric distention in healthy subjects
    • Akyuz F, Mimidis K, Nikolai H, Vos R, Tack J,. Influence of itopride and domperidone on gastric tone and on the perception of gastric distention in healthy subjects. Gastroenterology 2007; 132: A688.
    • (2007) Gastroenterology , vol.132
    • Akyuz, F.1    Mimidis, K.2    Nikolai, H.3    Vos, R.4    Tack, J.5
  • 17
    • 33746366470 scopus 로고    scopus 로고
    • Effects of itopride hydrochloride on plasma gut-regulatory peptide and stress-related hormone levels in healthy human subjects
    • Katagiri F, Shiga T, Inoue S, Sato Y, Itoh H, Takeyama M,. Effects of itopride hydrochloride on plasma gut-regulatory peptide and stress-related hormone levels in healthy human subjects. Pharmacology 2006; 77: 115-21.
    • (2006) Pharmacology , vol.77 , pp. 115-121
    • Katagiri, F.1    Shiga, T.2    Inoue, S.3    Sato, Y.4    Itoh, H.5    Takeyama, M.6
  • 18
    • 0027339679 scopus 로고
    • Review article: Promotility drugs in the treatment of gastro-oesophageal reflux disease
    • Ramirez B, Richter JE,. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1993; 7: 5-20.
    • (1993) Aliment Pharmacol Ther , vol.7 , pp. 5-20
    • Ramirez, B.1    Richter, J.E.2
  • 19
    • 20644451016 scopus 로고    scopus 로고
    • Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old
    • Pritchard DS, Baber N, Stephenson T,. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol 2005; 59: 725-9.
    • (2005) Br J Clin Pharmacol , vol.59 , pp. 725-729
    • Pritchard, D.S.1    Baber, N.2    Stephenson, T.3
  • 20
    • 0026523569 scopus 로고
    • Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study
    • Grande L, Lacima G, Ros E, et al. Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study. Dig Dis Sci 1992; 37: 583-8.
    • (1992) Dig Dis Sci , vol.37 , pp. 583-588
    • Grande, L.1    Lacima, G.2    Ros, E.3
  • 21
    • 33845383202 scopus 로고    scopus 로고
    • Neostigmine-induced postprandial phasic contractility in the proximal stomach and dyspepsia-like symptoms in healthy volunteers
    • Di Stefano M, Vos R, Klersy C, Lee KJ, Janssens J, Tack J,. Neostigmine-induced postprandial phasic contractility in the proximal stomach and dyspepsia-like symptoms in healthy volunteers. Am J Gastroenterol 2006; 101: 2797-804.
    • (2006) Am J Gastroenterol , vol.101 , pp. 2797-2804
    • Di Stefano, M.1    Vos, R.2    Klersy, C.3    Lee, K.J.4    Janssens, J.5    Tack, J.6
  • 22
    • 0033005156 scopus 로고    scopus 로고
    • Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism
    • Fang JC, Sarosiek I, Yamamoto Y, Liu J, Mittal RK,. Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism. Gut 1999; 44: 603-7.
    • (1999) Gut , vol.44 , pp. 603-607
    • Fang, J.C.1    Sarosiek, I.2    Yamamoto, Y.3    Liu, J.4    Mittal, R.K.5
  • 23
    • 0033958395 scopus 로고    scopus 로고
    • Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects
    • Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH,. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000; 118: 7-13.
    • (2000) Gastroenterology , vol.118 , pp. 7-13
    • Lidums, I.1    Lehmann, A.2    Checklin, H.3    Dent, J.4    Holloway, R.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.